Wilex AG
36Patents
18Active
36Granted
44Portfolio score
Filing activity: Sep 18, 1998 → Feb 21, 2014 · 13 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7608623B2 | Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors | Chemistry; Metallurgy | 15 | Expired |
| US7342018B2 | Urokinase inhibitors and uses thereof | Human Necessities | 12 | Expired |
| US7045504B2 | Cyclic peptidomimetic urokinase receptor antagonists | Human Necessities | 11 | Expired |
| US7211670B2 | Method for producing 3-amidinophenylalanine derivatives | Chemistry; Metallurgy | 9 | Expired |
| US7208521B2 | Selective inhibitors of the urokinase plasminogen activator | Chemistry; Metallurgy | 8 | Expired |
| US7049460B1 | Selective inhibitors of the urokinase plasminogen activator | Chemistry; Metallurgy | 8 | Expired |
| US7745441B1 | Urokinase inhibitors | Chemistry; Metallurgy | 8 | Expired |
| US7157238B2 | Diagnostic and therapeutic use of antibodies against the urokinase receptor | Chemistry; Metallurgy | 8 | Expired |
| US7713980B2 | Crystalline modifications of N-α-(2,4,6-triisopropyl-phenylsulfonyl)-3-hydroxyamidino-(L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof | Chemistry; Metallurgy | 7 | Active |
| US7038074B2 | Arginine mimetics as factor Xa inhibitors | Chemistry; Metallurgy | 7 | Expired |
| US9089532B2 | Stable dosage form of phenylalanine derivatives | Human Necessities | 6 | Active |
| US7538216B2 | Guanidino phenylalanin compounds used as urokinase inhibitors | Chemistry; Metallurgy | 6 | Expired |
| US7884206B2 | Method for producing 3-amidinophenylalanine derivatives | Chemistry; Metallurgy | 6 | Active |
| USRE46424E1 | Method for producing 3-amidinophenylalanine derivatives | General | 6 | Active |
| US7659396B2 | Method for the production of phenylalanine derivatives | Chemistry; Metallurgy | 6 | Active |
| US7951943B2 | Method for preparing and purifying 3-hydroxyamidinophenylalanine compounds | Chemistry; Metallurgy | 6 | Active |
| US8642761B2 | Method for producing 3-amidinophenylalanine derivatives | Chemistry; Metallurgy | 6 | Active |
| US6680320B2 | Urokinase inhibitors | Chemistry; Metallurgy | 6 | Expired |
| US7247724B2 | Method for the production of phenylalanine derivatives | Chemistry; Metallurgy | 6 | Expired |
| US8492385B2 | Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof | Chemistry; Metallurgy | 6 | Active |
| US7807681B2 | Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors | Chemistry; Metallurgy | 6 | Active |
| US7691375B2 | Adjuvant theraphy of G250-expressing tumors | Chemistry; Metallurgy | 2 | Expired |
| US7632496B2 | Co-administration of cG250 and IL-2 or IFN-α for treating cancer such as renal cell carcinomas | Human Necessities | 2 | Expired |
| US7399468B2 | Diagnostic and therapeutic use of antibodies against the urokinase receptor | Chemistry; Metallurgy | 2 | Active |
| US8828381B2 | Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.